Introduction
============

Menopause is the permanent cessation of menses, resulting from the reduced secretion of ovarian hormones namely estrogen and progesterone. This takes place as the finite store of ovarian follicles are depleted (Al-Safi et al., 2015). Thai women typically begin menopause at an age range of 48-52 years, with a median age of 51 years (Ongsupharn et al., 2018).

Cervical cancer screening is a simple tool that could be used to detect precancerous and cancerous cervical lesions. In many studies, it has been found that the most common cervical cytology is the atypical squamous cells of undetermined significance (ASC-US). This was shown in many studies in Thailand and other Southeast Asian countries (Laiwejpithaya et al., 2008; Tanabodee et al., 2015; Kingnate et al., 2016; Mu-Mu-Shwe et al., 2014; Hav et al., 2016). It is known that the cervical cytology of the ASC-US type is an atypical report that indicated either a low-risk or high grade cervical cytology abnormality. Therefore, treatment was still not a definite conclusion (Massad et al., 2013).

In 2012, the American Society for Colposcopy and Cervical Pathology (ASCCP) had revised the consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. According to ASCCP 2012, the acceptable management in women with ASC-US on cytology was either a repeat cytology at one year or an immediate human papillomavirus (HPV) testing (reflex test). Colposcopy was recommended in ASC-US cases with positive result of high risk HPV test (Massad et al., 2013).

Literatures showed that the prevalence of ASC-US cytology in menopausal women was 1.8 percent (Keating et al., 2001; Cakmak et al., 2014). Incidence of silent cervical intraepithelial neoplasia (CIN) 2/3 in menopausal women ranged from 1.8 to 6.1 percent (Tokmak et al., 2014; Goksedef et al., 2011).

The objective of this study was to evaluate the effect of obesity and BMI on remission, persistence and progression of the disease in pre and postmenopausal women with a cytology of ASC-US after initial management and a 2 year follow up. The prevalence of silent high grade cervical intraepithelial neoplasia (CIN 2/3 and cancer) in ASC-US cytology results in both groups of patients were studied.

Materials and Methods
=====================

This was a retrospective study, approved by the institutional review board, Bhumibol Adulyadej Hospital (BAH), Bangkok, Thailand (IRB: 18/62). Medical records stored in computerized systems were reviewed. Data from all patients with cervical cancer screening data in a 6 year period between January 2013 and October 2016 were enrolled. Inclusion criteria were women who had a cervical cytology result with ASC-US cytology. Exclusion criteria included pregnancy, hysterectomy and known histories of pre-invasive or invasive cervical lesions or other gynecologic cancers. Papanicolaou smears were performed using conventional (CPP) or liquid based cervical cytology (LBP) and evaluated according to the 2001 Bethesda. Subjects were then divided into pre and postmenopausal women groups. Demographic characteristics consisted of age, menstrual status, parity, screening proposal, history of sexually transmitted diseases (STD) including human immunodeficiency virus (HIV), number of sexual partners, smoking, alcohol consumption and education. Management of ASC-US cytology was followed by the previous ASCCP guideline by either a repeated cervical cytology testing in 6 months or a colposcopic directed biopsy (immediate colposcopy or positive high risk HPV test). Outcomes were classified as remission, persistent disease, completed and loss to follow-up after the initial of ASC-US management at a two year follow up appointment. Remission was defined as normal cervical cytology results at follow-up within two years. Persistent disease was defined as abnormal cervical cytology and colposcopic directed biopsy results at follow-up within two years. Completed and loss to follow-up were defined as a completion of cervical cytology or an absence of follow-up within two years.

The data was analyzed by using the SPSS statistical software version 18 (IBM, Armonk, NY, USA) for analysis. Descriptive statistics were used to analyze patient demographic data. Continuous variables were presented as mean and standard deviation (SD). Categorized data were expressed as number and percentage. Pearson Chi-square and Fisher's exact test were used in data analysis when appropriate. The p-value of less than or equal to 0.05 was considered to be statistical significance. Multivariable analysis of patient risk factors was calculated using binary logistic regression analysis and described as an odds ratio.

Results
=======

This study was conducted in the main hospital of the Royal Thai Air Force. In this study, around ninety percent of the premenopausal women were air force officers and employees while fifty percent of postmenopausal women were housewives. Participants were people who worked at and lived in the surrounding area of the hospital.

A total of 506 patients with ASC-US cytology were enrolled. Subjects underwent either immediate colposcopy or follow up cervical cytology after thorough counseling, at an incidence of 412 and 50 cases, respectively ([Figure 1](#F1){ref-type="fig"}).

The mean age of women in premenopausal versus postmenopausal women groups were 37.4 and 61.1 years, respectively. The participants in postmenopausal women had higher mean age of coitarche than premenopausal women with statistically significance (19.8 vs 17.9, p\< 0.001). Ninety-seven percent of cases in the postmenopausal women group were still sexually active.

Demographic data of subjects with ASC-US reports are presented in [Table 1](#T1){ref-type="table"}. There were 372 and 134 cases in pre and postmenopausal women group, respectively.

Half of the postmenopausal group was classified as unsatisfactory colposcopy (Type 3). It was more than those of the premenopausal women group with statistical significance as shown in [Table 2](#T2){ref-type="table"}. The histopathological results showed the prevalence of less than or equal to CIN 1 and CIN 2/3 in ASC-US cytology at 90.1/92.8 and 9.9/7.2 percent in pre and postmenopausal women groups, respectively. Women with conclusive results for CIN 2/3 underwent Cone biopsy either by either Loop Electrosurgical Excision Procedure (LEEP) or Cold Knife Conization (CKC) performed in those who had cervical biopsies of CIN 2/3. Neither micro invasive or invasive cervical cancer was found in both groups.

At two year follow-up periods, in immediate colposcopy arm, 233 patients (56.6%) had completed follow-up. Among non-obese cases, women in postmenopausal group had remission rate lower than premenopausal group with statically significant (91 vs 99 percent). Among obese women, remission rate of pre and postmenopausal women were equal. Among patients who chose follow up cervical cytology, remission rate of pre and postmenopausal women of the obese and non-obese categories were comparable. No progressive disease was shown in both groups including both management groups as presented in [Table 3](#T3){ref-type="table"}.

The multivariate analysis of correlation of the remission disease and clinical factors (including menopausal status, body mass index (BMI), sexual activity, parity, smoking and hormone replacement therapy) was performed as shown in [Table 4](#T4){ref-type="table"}. There was no significant correlation between clinical factors and the progression or regression of disease.
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###### 

Baseline Characteristics of Women Participating in This Study

  Characteristics           Pre          Post         *P-value*
  ------------------------- ------------ ------------ ----------------
  Age (years) \*            37.4 + 9.4   61.1 + 7.5   \< 0.001\*\*\*
  BMI (kg/m^2^)\*           22.7 + 4.1   25.5 + 4.6   \< 0.001\*\*\*
  Coitarche (years) \*      17.9 + 7.7   19.8 + 4.6   0.001\*\*\*
  Sexual intercourse\*\*    322 (86.6)   130 (97.0)   \<0.001\*\*\*
  Monogamy\*\*              340 (91.4)   119 (88.8)   0.375
  Parity\*\*                                          \<0.001\*\*\*
  0-1                       258 (69.4)   52 (38.8)    
  ≥ 2                       114 (30.6)   82 (61.2)    
  Screening proposal\*\*                              0.027
  Check up                  306 (82.3)   121 (90.3)   
  Others                    66(17.7)     13 (9.7)     
  Non smoking\*\*           368 (98.9)   132 (98.5)   0.658
  Alcohol consumption\*\*   6 (1.6)      2 (1.5)      1
  HIV positive\*\*          4 (1.1)      0 (0)        0.577
  Education\*\*                                       0.001\*\*\*
  Below bachelor            108 (29.0)   60 (44.8)    
  Bachelor or higher        264 (71.0)   74 (55.2)    
  LBP type\*\*              104 (28.0)   24 (17.9)    0.022\*\*\*
  Specimen adequacy\*\*     190 (51.1)   56 (41.8)    0.065
  BMI level                                           \< 0.001\*\*\*
  Normal                    222 (59.7)   46 (34.3)    
  Overweight                61 (16.4)    18 (13.4)    
  Obese                     89 (23.9)    70 (52.3)    
  Medical disease                                     \< 0.001\*\*\*
  No                        352 (94.6)   81 (60.4)    
  Yes                       20 (5.4)     53 (39.6)    

\*: mean + SD (standard deviation), \*\*: n (%), \*\*\*: The result is significant at p \<0.05, Pre: premenopausal women, Post: postmenopausal women, HIV: human immunodeficiency virus, LBP: liquid based cervical cytology, BMI: body mass index, Normal:

###### 

Results of Pre- and Postmenopausal Women who had Cytology of ASC-US

  ---------------------------------------------------------------------------
  Results                       Premenopause\    Postmenopause\   *p-value*
                                (n=314)          (n=98)           
  ----------------------------- ---------------- ---------------- -----------
  Colposcopic findings\*\*      \< 0.001\*\*\*                    

  Type 1/2                      232 (73.9)       46 (46.9)        

  Type 3                        82 (26.1)        52 (53.1)        

  Histopathologic results\*\*   0.4                               

  ≤ CIN 1                       283 (90.1)       91 (92.8)        

  CIN 2/3                       31 (9.9)         7 (7.2)          
  ---------------------------------------------------------------------------

\*\*: n (%), \*\*\*: The result is significant at p\<0.05, ASC-US: atypical squamous cells of undetermined significance, ≤ CIN 1: cervical intraepithelial neoplasia grade 1 or less, CIN 2/3: cervical intraepithelial neoplasia grade 2 and 3.

###### 

Results of Pre- and Postmenopausal Women who had Completed a 2-Year F/U

  Characteristics   Non-obese    *p-value*   Obese         *p-value*              
  ----------------- ------------ ----------- ------------- ----------- ---------- -------
  IC Arm                                     0.010\*\*\*                          0.369
  Remission         115 (99.1)   32 (91.4)                 47 (95.9)   33 (100)   
  Persisted         1 (0.9)      3 (8.6)                   2 (4.1)     0 (0)      
  F/U Arm                                    0.505                                0.472
  Remission         15 (100)     11 (100)                  11 (100)    9 (90)     
  Persisted         0 (0)        0 (0)                     0 (0)       1 (10)     

Pre: premenopausal women, Post: postmenopausal women, IC: immediate colposcopy, F/U: follow up, Remission: remission of disease, Persisted: persistent of disease, Non-obese: BMI 18.5-29.9 kg/m^2^, Obese, BMI \> 30 kg/m^2^; \*\*\*: The result is significant at p\<.05

###### 

Correlation of the Remission of Disease and Patient Factors by Multivariate Analysis

  Factors                     Remission   Persisted   OR (95% CI)         *P-value*
  --------------------------- ----------- ----------- ------------------- -----------
  Menopausal status                                                       
  Premenopause                188         3           3.12 (0.57-17.09)   0.189
  Postmenopause               75          3           0.31(0.05-1.64)     0.169
  BMI                                                                     
  Normal                      128         3           1.01 (0.18-5.61)    0.983
  Overweight                  40          0           3.03                0.998
  Obese                       95          3           0.92 (0.17-4.92)    0.922
  Sexual intercourse                                                      
  No                          31          0           2.24                0.998
  Yes                         232         6           0                   0.998
  Number of sexual partners                                               
  0-1                         237         6           0                   0.998
  ≥ 2                         26          0           5.36                0.998
  Parity                                                                  
  0-1                         171         3           1.97 (0.34-11.26)   0.445
  ≥ 2                         92          3           0.51 (0.08-2.89)    0.445
  Smoking                                                                 
  No                          260         6           2.78                1
  Yes                         3           0           0.23                1
  HRT used                                                                
  No                          259         6           0                   0.999
  Yes                         4           0           1.16                0.999

BMI, body mass index; Normal, BMI 18.5-22.9 kg/m^2^; Overweight, BMI 23-29.9 kg/m^2^; Obese, BMI \> 30 kg/m^2^; HRT, hormone replacement therapy; Remission, remission of disease; Persisted, persistent of disease; OR, odds ratio; CI, confidence interval; \*\*, The result is significant at p \< 0.05

Discussion
==========

ASC-US is the most common cytological abnormality in cervical cytology. It carried the lowest risk of CIN 3 or cancer because one third to two third was not HPV associated (Katki et al., 2013).

Age of coitarche in the premenopausal group was lower than that of the postmenopausal group (17 and 19 years, respectively). These findings might be the result of different occupations and life styles among both groups in this study. Half of the postmenopausal group were housewives while eighty percent of premenopausal group were employees in either government or the private sector.

Most of both groups were monogamous, non-smokers and non-consumers of alcohol (in line with demographic trends of Thai women). However, the effect of the second hand cigarette smoke could not be evaluated.

In the current study, mean BMI of the postmenopausal women was higher than that of the premenopausal women (25.5 vs 22.7 kg/m^2^). Abnormal BMI level indicated overweight and obese status. Two third of postmenopausal women in the present study had abnormal BMI. Fifty percent of this group had BMI in obese ranges. The findings were comparable to the results from Chen KL et al that reported increasing prevalence of overweight and obesity in 70 percent of postmenopausal women (Chen et al., 2018).

From the present study, postmenopausal women were more likely to be obese and have underlying diseases including diabetes mellitus, hypertension and cardiovascular disease, similar to the findings reported in previous literature (Krychman et al., 2015). According to 2003-2012 National Health and Nutrition Examination Survey (NHANES) data, metabolic syndrome presented in about 34 percent of the population and the rates of metabolic syndrome were increasing among postmenopausal women (Chen et al., 2018). Among postmenopausal women in this study, there was a forty percent incidence of metabolic disease. The rate of findings was comparable to the previous literature.

The rate of inadequate colposcopy in postmenopausal women in this investigation was significantly higher than that of the premenopausal women (53.1 and 26.1 %, respectively). This finding was a consequence of physiologic migration of the squamocolumnar junction (SCJ) to the cervical opening. Local estrogen therapy to the cervicovaginal region improved the adequacy of colposcopic examination (Goksedef et al., 2011; Richards et al., 2015).

In the current study, the prevalence of silent CIN2/3 in ASC-US cytology were 9.9 and 7.2 percent in pre and postmenopausal groups, respectively. Both groups had high prevalence of high grade CIN. Thus we recommended that all women with ASC-US cytology results should undergo colposcopic directed biopsy. Our recommendation differed from the American Society for Colposcopy and Cervical Pathology (ASCCP) guidelines that recommended colposcopy in persistent ASC-US cytology or concomitant with positive high risk HPV (Massad et al., 2013).

Among non-obese cases in both pre and postmenopausal groups, persistence rates of abnormal cervical cytology of the postmenopausal group was higher than that of the premenopausal group (3/35 and 1/116, respectively). Using binary logistic regression analysis, no statistically significant links were found between remission rates of abnormal cervical cytology and patient factors (including menopausal status, BMI, sexual activity, parity, smoking and HRT). Among postmenopausal women with obese BMIs, there was a slightly lower rate of disease regression, but this was found to not be statistically significant. This was explained by the alteration of host immunity (Liu et al., 2013). Age was an important risk factor for a persistent HPV infection due to decreasing immune function in the elderly. HPV was hard to be clear after its acquisition (Sui et al., 2018).

Obesity was a result of disruption of energy balance that led to weight gain and metabolic disturbances that causes tissue stress and dysfunction. Metabolic disturbances lead to immune activation in tissue such as adipose tissue, liver, pancreas and vasculature. These effects may increase the risk for other infectious and chronic diseases (Andersen et al., 2016). However menopause was often accompanied by redistribution of adipose tissue from the periphery to the abdomen, hip and thigh. Central obesity has been associated with a pro-inflammatory state in postmenopausal women. Adiposity had been linked to increased susceptibility to viral pathogens, such as herpes simplex virus-1 and -2 and adenovirus-36 (Liu et al., 2013). In particular, Baker et al (Baker et al., 2011) showed increased levels of adipokines in older women with persistent HPV infection.

The limitations of this study were its nature as a retrospective study. Demographic data and further follow-ups of cervical cytology were not completed.

There was no data on blood hormonal, adipokine and immunological factor levels in our retrospective data. It would cause of remission or persistence of disease in women with BMI status in obese level between pre and postmenopausal women with no difference. Therefore, this topic should be of concern and merits further study.

In conclusion, in postmenopausal women, obesity might have a link on the remission rate. Cervical cytology follow-up should be prescribed in this population. However, obesity was not correlated with progression or regression of CIN, and further studies should be done to clarify the relationship. The prevalence of silent high grade CIN in ASC-US cases in pre and postmenopausal women were higher than the data of ASCCP guideline. Based on our patient population, we recommended immediate colposcopy in all women who had cervical cytology report of ASC-US without HPV testing result. The suggestion might be applied to the referral centers with high incidence of silent high grade CIN.
